Mathematician and bioengineer Sarah Nelson, PhD, and pharmacist Marcus Ferrone, PharmD, apply nuclear magnetic resonance imaging and a new chemical compound to assess the aggressiveness of prostate cancer in patients and the success of prostate cancer therapies. Nelson is a faculty member in the Department of Bioengineering and Therapeutic Sciences, UCSF Schools of Pharmacy and Medicine. Ferrone is a faculty member in the Department of Clinical Pharmacy, UCSF School of Pharmacy.
Link to this comment:
All Comments (0)